1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow HCV: new trials by email Literature Review of HCV trials Research Report on HCV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures Eltrombopag, Placebo - Non-alcoholic Steatohepatitis, Chronic Liver Disease | Phase 3 | Terminated | GlaxoSmithKline | 292 | 2008-06-01 | 2018-10-12 |
Acquired Immunodeficiency Syndrome (1) · HIV Infections (1) · Hepatitis B (1) · Hepatitis C (1) · Jacobs syndrome (1) · Liver Diseases (1) · Non-alcoholic Fatty Liver Disease (1) · Thrombocytopenia (1)
Blood Platelet Disorders (1) · Blood-Borne Infections (1) · Communicable Diseases (1) · Cytopenia (1) · DNA Virus Infections (1) · Digestive System Diseases (1) · Fatty Liver (1) · Flaviviridae Infections (1) · Genital Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hepadnaviridae Infections (1) · Hepatitis (1) · Hepatitis, Viral, Human (1) · Immune System Diseases (1)
eltrombopag (1)
GlaxoSmithKline (1)
Argentina (1) · Belgium (1) · Canada (1) · France (1) · India (1) · Italy (1) · Pakistan (1) · Poland (1) · Russia (1) · South Korea (1) · Spain (1) · Taiwan (1) · United States (1)